Figure 6 and Table S4 depict sensitivity and specificity levels obtained for the training and the validation sets by using the candidate 51-gene PR gene signature or by using a single probe set (208305_at) to assess PR status in breast tumor specimens. This evidence concerns the gene PGR and breast neoplasm.